Q3 2026 13F filing
Updated 6 days ago115 disclosed positions worth $707.5M
Full holdings
Every line item disclosed in Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | M MINERALYS THERAPEUTICS INC | $33.2M | 1.32M | 4.70% | — |
| 2 | T TEVA PHARMACEUTICAL INDS LTD | $31.1M | 786.3K | 4.40% | — |
| 3 | A ALNYLAM PHARMACEUTICALS INC | $29.8M | 120.6K | 4.21% | — |
| 4 | C CYTOKINETICS INC | $23.9M | 361.9K | 3.37% | — |
| 5 | E ISHARES TR | $21M | 37.0K | 2.97% | — |
| 6 | B BRIDGEBIO PHARMA INC | $20.5M | 311.7K | 2.90% | — |
| 7 | T TOWER SEMICONDUCTOR LTD | $19.3M | 84.7K | 2.72% | — |
| 8 | S SYNDAX PHARMACEUTICALS INC | $18.9M | 1.01M | 2.68% | — |
| 9 | B BIOMARIN PHARMACEUTICAL INC | $17.6M | 293.2K | 2.49% | — |
| 10 | B BIOGEN INC | $17.1M | 75.8K | 2.42% | — |
| 11 | C COGENT BIOSCIENCES INC | $16.1M | 501.5K | 2.27% | — |
| 12 | A NOVA LTD | $15M | 39.0K | 2.13% | — |
| 13 | M MADRIGAL PHARMACEUTICALS INC | $13M | 25.8K | 1.84% | — |
| 14 | S SPDR SERIES TRUST | $11.8M | 75.0K | 1.67% | — |
| 15 | M META PLATFORMS INC | $11.7M | 16.2K | 1.66% | — |
| 16 | I IMMATICS N.V | $11.5M | 1.30M | 1.62% | — |
| 17 | S SANOFI SA | $11.1M | 269.5K | 1.57% | — |
| 18 | A ASTRAZENECA PLC | $11.1M | 68.5K | 1.56% | — |
| 19 | D ARK ETF TR | $10.8M | 200.0K | 1.53% | — |
| 20 | M MAZE THERAPEUTICS INC | $10M | 366.3K | 1.41% | — |
| 21 | L ELI LILLY & CO | $9.3M | 8.0K | 1.31% | — |
| 22 | K KLA CORP | $8.8M | 45.2K | 1.25% | — |
| 23 | L LAM RESEARCH CORP | $8.5M | 25.9K | 1.20% | — |
| 24 | P PFIZER INC | $8.2M | 286.0K | 1.15% | — |
| 25 | I IDEAYA BIOSCIENCES INC | $8.1M | 211.4K | 1.15% | — |
| 26 | R RHYTHM PHARMACEUTICALS INC | $7.7M | 80.4K | 1.08% | — |
| 27 | J JOHNSON & JOHNSON | $7.6M | 28.8K | 1.08% | — |
| 28 | T TANGO THERAPEUTICS INC | $7.6M | 304.3K | 1.07% | — |
| 29 | I DISC MEDICINE INC | $7.5M | 114.7K | 1.06% | — |
| 30 | V VOR BIOPHARMA INC | $7.3M | 383.4K | 1.03% | — |
| 31 | A APPLIED MATLS INC | $7.3M | 14.3K | 1.03% | — |
| 32 | A ABIVAX SA | $7.3M | 73.7K | 1.03% | — |
| 33 | P PHARVARIS N V | $7.3M | 229.7K | 1.03% | — |
| 34 | C CAMTEK LTD | $7.3M | 46.8K | 1.03% | — |
| 35 | M MERCK & CO INC | $7.1M | 48.6K | 1.00% | — |
| 36 | N NUVECTIS PHARMA INC | $6.8M | 323.4K | 0.97% | — |
| 37 | N NOVARTIS AG | $6.4M | 45.0K | 0.91% | — |
| 38 | A ABBVIE INC | $5.8M | 22.3K | 0.82% | — |
| 39 | T FIRST TRACKS BIOTHERAPEUTICS | $5.7M | 160.2K | 0.80% | — |
| 40 | T TREVI THERAPEUTICS INC | $5.5M | 385.3K | 0.78% | — |
| 41 | M SATELLOS BIOSCIENCE INC | $5.4M | 638.7K | 0.77% | — |
| 42 | A ANNEXON INC | $5.2M | 1.22M | 0.73% | — |
| 43 | R ULTRAGENYX PHARMACEUTICAL IN | $5.1M | 338.6K | 0.72% | — |
| 44 | ? N/A CLIMB BIO INC | $4.8M | 416.7K | 0.68% | — |
| 45 | H CYBIN INC | $4.8M | 388.2K | 0.67% | — |
| 46 | O ORIC PHARMACEUTICALS INC | $4.7M | 349.4K | 0.67% | — |
| 47 | R REVOLUTION MEDICINES INC | $4.6M | 22.4K | 0.65% | — |
| 48 | N NOVO-NORDISK A S | $4.6M | 120.7K | 0.65% | — |
| 49 | E ENLIVEN THERAPEUTICS INC | $4.6M | 99.8K | 0.65% | — |
| 50 | T TENAX THERAPEUTICS INC | $4.4M | 2.32M | 0.62% | — |